Mediantechnologies Aktie
2,68 €
Deine Einschätzung
Mediantechnologies Aktie
Was spricht für und gegen Mediantechnologies in den nächsten Jahren?
Pro
Kontra
Rendite von Mediantechnologies im Vergleich
Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
---|---|---|---|---|---|---|---|
Mediantechnologies | 3,28 % | - | - | - | - | - | - |
Coheris S.A. Inh. | 0,69 % | 14,96 % | 21,92 % | 65,91 % | 22,18 % | 212,30 % | 205,76 % |
Acteos | 0,40 % | -2,75 % | -0,40 % | -19,48 % | 6,44 % | -55,71 % | 2,06 % |
Netgem S.A. | -0,22 % | -1,92 % | -2,75 % | -8,91 % | -6,69 % | -23,33 % | -21,37 % |
Kommentare
News
Median Technologies Reports Full-year 2023 Financial Results and Provides First Quarter 2024 Financial Information
Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, “Median” or the “Company”) today reported its 2023 consolidated annual financial results, as of December 31
Median Technologies to Participate in the TD Cowen’s 44th Annual Health Care Conference
Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA/SME eligible) (Paris:ALMDT), will be participating in the TD Cowen’s 44th Annual Health Care Conference, taking place on March 4 –
Median Technologies to Participate and Speak at the 2024 European Congress of Radiology (ECR), February 28 – March 3, Vienna, Austria
Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA/SME eligible) announces today that the Company will be participating and speaking at the premier European radiology conference, the